Dr. Anne Cheever joined DARPA as a program manager in August 2020. She is interested in novel approaches to biosecurity, as well as the use of bioengineering, bioinformatics, and genome editing technologies for innovative biotechnological applications.
Prior to joining DARPA, Cheever was a lead biotechnologist at MITRE Corporation, where she provided scientific and strategic support to multiple federal institutions in the areas of biodefense, biosecurity, disruptive technologies, and emerging infectious disease. She also led a team focused on COVID-19 vaccine acceleration, communications, security, and data analytics in support of Operation Warp Speed (OWS) and the Department of Defense (DoD). Previously, Cheever was a senior lead scientist at Booz Allen Hamilton, where she contributed to the development of capabilities in synthetic biology and biosecurity for intrinsic and extrinsic control of genome editors and gene drives.
Cheever is a former fellow of the Johns Hopkin’s Center for Health Security Emerging Leaders in Biosecurity Initiative and an alumni of the American Association for the Advancement of Science (AAAS) Science and Technology Policy Fellowship.
Cheever received her Doctor of Philosophy degree in cell and developmental biology, Bachelor of Science degree in ecology, ethology, and evolution; and certificate in business administration from the University of Illinois at Urbana-Champaign.
All times are presented in the host university’s local time zone.
Hardening Supply Networks for the Future
(3:15pm - 4:00pm)